CareCloud Announces Approval of Series A Preferred Stock Proposal
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leading healthcare technology solutions provider, has announced the approval of its Series A Preferred Stock Proposal at a reconvened special meeting. Shareholders representing over two-thirds of the outstanding Series A Preferred Stock approved the proposal, which includes an amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock.
The approval marks a significant development for CareCloud, potentially impacting its capital structure and shareholder rights. Investors are advised to review the complete Definitive Proxy Statement and related materials filed with the SEC for comprehensive details about the changes and their implications.
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), un fornitore leader di soluzioni tecnologiche per la salute, ha annunciato l'approvazione della sua Proposta di Azioni Preferenziali di Serie A durante una riunione speciale riconvocata. Gli azionisti che rappresentano oltre i due terzi delle Azioni Preferenziali di Serie A in circolazione hanno approvato la proposta, che include una modifica al Certificato di Designazioni, Preferenze e Diritti delle Azioni Preferenziali di Serie A della società.
L'approvazione segna uno sviluppo significativo per CareCloud, con potenziali ripercussioni sulla sua struttura di capitale e sui diritti degli azionisti. Si consiglia agli investitori di esaminare il completo Documento di Voto Definitivo e i materiali correlati depositati presso la SEC per ulteriori dettagli sulle modifiche e le loro implicazioni.
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), un proveedor líder de soluciones tecnológicas para la salud, ha anunciado la aprobación de su Propuesta de Acciones Preferentes de Serie A en una reunión especial reconvocada. Los accionistas que representan más de dos tercios de las Acciones Preferentes de Serie A en circulación aprobaron la propuesta, que incluye una enmienda al Certificado de Designaciones, Preferencias y Derechos de sus Acciones Preferentes de Serie A.
La aprobación marca un desarrollo significativo para CareCloud, pudiendo impactar su estructura de capital y los derechos de los accionistas. Se recomienda a los inversores revisar el Documento Definitivo de Poder y los materiales relacionados presentados ante la SEC para obtener detalles completos sobre los cambios y sus implicaciones.
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP)는 의료 기술 솔루션의 선두 제공업체로서 재개된 특별 회의에서 시리즈 A 우선주 제안의 승인을 발표했습니다. 시리즈 A 우선주의 발행 주식의 3분의 2 이상을 차지하는 주주들이 제안을 승인했습니다, 이는 회사의 시리즈 A 우선주의 디자인, 선호도 및 권리에 대한 인증서의 수정안을 포함합니다.
이번 승인은 CareCloud에 중요한 발전을 의미하며, 자본 구조와 주주권에 영향을 미칠 수 있습니다. 투자자는 SEC에 제출된 전체 최종 대리인 성명서와 관련 자료를 검토하여 변경 사항 및 그 의미에 대한 포괄적인 세부정보를 확인하는 것이 좋습니다.
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), un fournisseur leader de solutions technologiques dans le secteur de la santé, a annoncé l'approbation de sa proposition d'actions privilégiées de série A lors d'une réunion spéciale reconvoquée. Les actionnaires représentant plus des deux tiers des actions privilégiées de série A en circulation ont approuvé la proposition, qui inclut un amendement au certificat de désignation, de préférences et de droits de ses actions privilégiées de série A.
Cette approbation marque un développement significatif pour CareCloud, avec un impact potentiel sur sa structure de capital et les droits des actionnaires. Les investisseurs sont conseillés à examiner l'intégralité de la déclaration de procuration définitive et des documents connexes déposés auprès de la SEC pour des détails complets sur les changements et leurs implications.
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), ein führender Anbieter von Technologien im Gesundheitswesen, hat die Genehmigung seines Vorschlags zu den Vorzugsaktien der Serie A bei einer einberufenen Sonderversammlung bekanntgegeben. Aktionäre, die über zwei Drittel der ausstehenden Vorzugsaktien der Serie A vertreten, haben den Vorschlag genehmigt, der eine Änderung des Zertifikats für Designationen, Präferenzen und Rechte der Vorzugsaktien der Serie A des Unternehmens umfasst.
Die Genehmigung stellt eine bedeutende Entwicklung für CareCloud dar und könnte Auswirkungen auf die Kapitalstruktur und die Aktionärsrechte haben. Investoren wird geraten, die vollständige endgültige Vollmachtserklärung und die relevanten Materialien, die bei der SEC eingereicht wurden, zu überprüfen, um umfassende Details zu den Änderungen und deren Auswirkungen zu erhalten.
- Approval of Series A Preferred Stock Proposal by over two-thirds majority
- Successful reconvening of special meeting for important shareholder vote
- None.
CareCloud's approval of the Series A Preferred Stock proposal marks a significant development for the company's capital structure. This move could potentially enhance financial flexibility and improve the company's ability to raise capital in the future. The two-thirds majority approval indicates strong shareholder support, which is often viewed positively by the market.
However, without specific details on the amendments, it's challenging to fully assess the impact. Investors should closely monitor any changes to dividend rates, redemption terms, or voting rights that may affect the stock's value and the company's financial obligations. This development may also signal potential strategic shifts or upcoming corporate actions that could influence CareCloud's market position in the healthcare technology sector.
The approval of the Preferred Stock Proposal demonstrates CareCloud's commitment to shareholder engagement and corporate governance best practices. Achieving a two-thirds majority for such a proposal is noteworthy, suggesting strong alignment between management and preferred shareholders.
Investors should pay attention to the specific amendments in the Certificate of Designations, as these changes could affect the balance of power between different classes of shareholders. It's important to understand how these modifications might impact shareholder rights, dividend policies and the company's capital allocation strategies. This move could potentially set a precedent for future governance decisions and shareholder relations at CareCloud.
SOMERSET, N.J., Sept. 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today reconvened its special meeting (“Special Meeting”) of CareCloud’s Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) shareholders. At the Special Meeting, shareholders representing more than two-thirds of the outstanding shares of Series A Preferred Stock approved the preferred stock proposal, which included an amendment to the Company’s Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”).
The information contained in this press release is a summary of certain relevant portions of the Definitive Proxy Statement and other materials filed with the SEC. The entirety of the filings are available on the SEC’s website and on https://ir.carecloud.com/series-a-special-proxy.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
SOURCE CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Bill Korn
CareCloud, Inc.
ir@carecloud.com
FAQ
What was the outcome of CareCloud's (CCLD) special meeting for Series A Preferred Stock shareholders?
What does the approval of the Series A Preferred Stock Proposal mean for CareCloud (CCLD)?
Where can investors find more information about CareCloud's (CCLD) Series A Preferred Stock Proposal?
